Sotorasib,adagrasib,Cetuximab,Afatinib,Pembrolizumab,JDQ443,tislelizumab,GDC-6036,alectinib,Atezolizumab,gemcitabine,Entrectinib,Cobimetinib,Vemurafenib,bevacizumab,Adagrasib,Docetaxel
Amgen,mirati,Eli Lilly,Boehringer Ingelheim,Merck,Novartis,Beigene,Roche,Daiichi Sankyo,Sanofi,Aventis,Novartis
['nsclc', 'sclc']
. nicely reviewed how we went from the undruggible krasm #nsclc to having 2 approved and 2 experimental therapies.#esmo22 
Med affairs lead for Dx; Duke adjunct; PI. Mom of 2 boys & Army wife. Tweets are my own, retweets are not endorsements. Personal account. GO BIG RED.